Filed: 5/15/2025ACC: 0001802630-25-000006
📋 What this filing means
SOLEUS CAPITAL MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 75 equity positions with a total reported market value of $1.39B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
75
Positions
$1.39B
Total AUM (reported)
121.83M
Total Shares
Allocation by class
COM$840.66M60.5%
COM NEW$121.56M8.8%
S&P BIOTECH$113.54M8.2%
ORD SHS$98.39M7.1%
SPONSORED ADR$52.78M3.8%
SP ADR REP B NVT$50.41M3.6%
COM PAR $0.01$45.18M3.3%
Portfolio Concentration
Top 3$324.18M23.3%
4–10$396.51M28.5%
11–25$366.95M26.4%
Rest$301.29M21.7%
Top 3 weight
23.3%
Top 10 weight
51.9%
Voting Authority Distribution
Total shares with voting rights: 121.83M
Sole
Full voting authority
121.83M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole75
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings75
Rows:
SPDR SER TR
SOLEShares1.40M
TypeSH
Market value$113.54M
8.17%
Sole
1.40M
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares2.85M
TypeSH
Market value$112.25M
8.08%
Sole
2.85M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares5.52M
TypeSH
Market value$98.39M
7.08%
Sole
5.52M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares441.76K
TypeSH
Market value$79.65M
5.73%
Sole
441.76K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares1.08M
TypeSH
Market value$76.30M
5.49%
Sole
1.08M
Shared
0.00
None
0.00
ORGANOGENESIS HLDGS INC
SOLEShares12.48M
TypeSH
Market value$53.91M
3.88%
Sole
12.48M
Shared
0.00
None
0.00
GRIFOLS S A
SOLEShares7.09M
TypeSH
Market value$50.41M
3.63%
Sole
7.09M
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares155.39K
TypeSH
Market value$47.90M
3.45%
Sole
155.39K
Shared
0.00
None
0.00
STAAR SURGICAL CO
SOLEShares2.56M
TypeSH
Market value$45.18M
3.25%
Sole
2.56M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares1.14M
TypeSH
Market value$43.16M
3.11%
Sole
1.14M
Shared
0.00
None
0.00
BETA BIONICS INC
SOLEShares3.40M
TypeSH
Market value$41.56M
2.99%
Sole
3.40M
Shared
0.00
None
0.00
NEUROPACE INC
SOLEShares2.61M
TypeSH
Market value$32.05M
2.31%
Sole
2.61M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares2.42M
TypeSH
Market value$28.78M
2.07%
Sole
2.42M
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares1.45M
TypeSH
Market value$26.75M
1.93%
Sole
1.45M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares2.57M
TypeSH
Market value$26.02M
1.87%
Sole
2.57M
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares7.79M
TypeSH
Market value$25.92M
1.87%
Sole
7.79M
Shared
0.00
None
0.00
SURMODICS INC
SOLEShares789.06K
TypeSH
Market value$24.09M
1.73%
Sole
789.06K
Shared
0.00
None
0.00
INTEGRA LIFESCIENCES HLDGS C
SOLEShares1.07M
TypeSH
Market value$23.58M
1.70%
Sole
1.07M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares8.17M
TypeSH
Market value$22.54M
1.62%
Sole
8.17M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares67.50K
TypeSH
Market value$22.36M
1.61%
Sole
67.50K
Shared
0.00
None
0.00
INSMED INC
SOLEShares274.27K
TypeSH
Market value$20.92M
1.51%
Sole
274.27K
Shared
0.00
None
0.00
RIGEL PHARMACEUTICALS INC
SOLEShares1.13M
TypeSH
Market value$20.34M
1.46%
Sole
1.13M
Shared
0.00
None
0.00
HOLOGIC INC
SOLEShares302K
TypeSH
Market value$18.65M
1.34%
Sole
302K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares28.94K
TypeSH
Market value$17.13M
1.23%
Sole
28.94K
Shared
0.00
None
0.00
MERUS N V
SOLEShares385.82K
TypeSH
Market value$16.24M
1.17%
Sole
385.82K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SER TRSOLE | S&P BIOTECH | 1.40M | SH | $113.54M 8.17% | 1.40M | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 2.85M | SH | $112.25M 8.08% | 2.85M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | ORD SHS | 5.52M | SH | $98.39M 7.08% | 5.52M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 441.76K | SH | $79.65M 5.73% | 441.76K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 1.08M | SH | $76.30M 5.49% | 1.08M | 0.00 | 0.00 |
ORGANOGENESIS HLDGS INCSOLE | COM | 12.48M | SH | $53.91M 3.88% | 12.48M | 0.00 | 0.00 |
GRIFOLS S ASOLE | SP ADR REP B NVT | 7.09M | SH | $50.41M 3.63% | 7.09M | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 155.39K | SH | $47.90M 3.45% | 155.39K | 0.00 | 0.00 |
STAAR SURGICAL COSOLE | COM PAR $0.01 | 2.56M | SH | $45.18M 3.25% | 2.56M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 1.14M | SH | $43.16M 3.11% | 1.14M | 0.00 | 0.00 |
BETA BIONICS INCSOLE | COM | 3.40M | SH | $41.56M 2.99% | 3.40M | 0.00 | 0.00 |
NEUROPACE INCSOLE | COM | 2.61M | SH | $32.05M 2.31% | 2.61M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 2.42M | SH | $28.78M 2.07% | 2.42M | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 1.45M | SH | $26.75M 1.93% | 1.45M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 2.57M | SH | $26.02M 1.87% | 2.57M | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 7.79M | SH | $25.92M 1.87% | 7.79M | 0.00 | 0.00 |
SURMODICS INCSOLE | COM | 789.06K | SH | $24.09M 1.73% | 789.06K | 0.00 | 0.00 |
INTEGRA LIFESCIENCES HLDGS CSOLE | COM NEW | 1.07M | SH | $23.58M 1.70% | 1.07M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 8.17M | SH | $22.54M 1.62% | 8.17M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 67.50K | SH | $22.36M 1.61% | 67.50K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 274.27K | SH | $20.92M 1.51% | 274.27K | 0.00 | 0.00 |
RIGEL PHARMACEUTICALS INCSOLE | COM | 1.13M | SH | $20.34M 1.46% | 1.13M | 0.00 | 0.00 |
HOLOGIC INCSOLE | COM | 302K | SH | $18.65M 1.34% | 302K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 28.94K | SH | $17.13M 1.23% | 28.94K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 385.82K | SH | $16.24M 1.17% | 385.82K | 0.00 | 0.00 |
Page 1 of 3